How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

5,692 results for

Gestational Diabetes Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Prevalence of diabetes mellitus after gestational diabetes mellitus: a meta-analysis

Prevalence of diabetes mellitus after gestational diabetes mellitus: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites (...) meta-analysis. Example: Because of the exploratory nature of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis

2019 PROSPERO

182. Diabetes prevention programs for women after gestational diabetes: an overview of reviews

Diabetes prevention programs for women after gestational diabetes: an overview of reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites (...) meta-analysis. Example: Because of the exploratory nature of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis

2019 PROSPERO

183. A qualitative synthesis of clinicians' views towards screening for type 2 diabetes after gestational diabetes

A qualitative synthesis of clinicians' views towards screening for type 2 diabetes after gestational diabetes Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files (...) , see the and to pre-clinical meta-analysis. Example: Because of the exploratory nature of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control

2019 PROSPERO

184. Reducing cardiovascular risk and preventing diabetes following gestational diabetes: a systematic review of interventions including a digital or telemedicine component

Reducing cardiovascular risk and preventing diabetes following gestational diabetes: a systematic review of interventions including a digital or telemedicine component Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability (...) will yield the same results as the fixed-effect model. For further details, see the and to pre-clinical meta-analysis. Example: Because of the exploratory nature of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than

2019 PROSPERO

185. Postpartum screening uptake, progression to type 2 diabetes and screening practices in women with a known history of gestational diabetes: a systematic review and meta-analysis

Postpartum screening uptake, progression to type 2 diabetes and screening practices in women with a known history of gestational diabetes: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email (...) of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group

2019 PROSPERO

186. Pharmacological intervention for type 2 diabetes prevention in women with prior gestational diabetes: a systematic review and meta-analysis

Pharmacological intervention for type 2 diabetes prevention in women with prior gestational diabetes: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne (...) will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group by the number of treatment groups served. Where

2019 PROSPERO

187. A realist review of the use of reminder systems for follow-up screening and early detection of type 2 diabetes in women with previous gestational diabetes

A realist review of the use of reminder systems for follow-up screening and early detection of type 2 diabetes in women with previous gestational diabetes Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content (...) the same results as the fixed-effect model. For further details, see the and to pre-clinical meta-analysis. Example: Because of the exploratory nature of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one

2019 PROSPERO

188. The Gestational Diabetes Management System (GooDMomS): development, feasibility and lessons learned from a patient-informed, web-based pregnancy and postpartum lifestyle intervention. Full Text available with Trip Pro

The Gestational Diabetes Management System (GooDMomS): development, feasibility and lessons learned from a patient-informed, web-based pregnancy and postpartum lifestyle intervention. Gestational diabetes mellitus (GDM) contributes to the epidemic of diabetes and obesity in mothers and their offspring. The primary objective of this pilot study was to: 1) refine the GDM Management System (GooDMomS), a web-based pregnancy and postpartum behavioral intervention and 2) assess the feasibility (...) in the GooDMomS program. Participants received web lessons, self-tracking of weight and glucose, automated feedback and access to a message board for peer support. The primary outcome was feasibility, including recruitment and retention and acceptability. Secondary outcomes included the proportion of women whose gestational weight gain (GWG) was within the Institute of Medicine (IOM) guidelines and who were able to return to their pre-pregnancy weight after delivery.Comments from semi-structured interviews

2016 BMC Pregnancy and Childbirth

189. Trial protocol to compare the efficacy of a smartphone-based blood glucose management system with standard clinic care in the gestational diabetic population. Full Text available with Trip Pro

Trial protocol to compare the efficacy of a smartphone-based blood glucose management system with standard clinic care in the gestational diabetic population. The prevalence of gestational diabetes mellitus (GDM) is rising in the UK. Good glycaemic control improves maternal and neonatal outcomes. Frequent clinical review of patients with GDM by healthcare professionals is required owing to the rapidly changing physiology of pregnancy and its unpredictable course. Novel technologies that allow (...) and neonatal outcomes compared to standard clinic care in a single large publicly funded (National Health Service (NHS)) maternity unit.Women with confirmed gestational diabetes in a current pregnancy are individually randomised to either the GDm-health system and half the normal clinic visits or normal clinic care. Primary outcome is mean BG in each group from recruitment to delivery calculated, with adjustments made for number of BG measurements, proportion of preprandial and postprandial readings

2016 BMJ open Controlled trial quality: uncertain

190. Postpartum glucose follow-up and lifestyle management after gestational diabetes mellitus: general practitioner and patient perspectives Full Text available with Trip Pro

Postpartum glucose follow-up and lifestyle management after gestational diabetes mellitus: general practitioner and patient perspectives Incidence of type 2 diabetes is high after gestational diabetes mellitus (GDM). We aimed to evaluate the adherence to follow-up six-weeks postpartum visits in secondary care after GDM and glucose monitoring in primary care longer than 12-14 months after delivery and the years thereafter. In addition, we examined the women's lifestyle after delivery.A cross (...) postpartum visit at the diabetes outpatient clinic and in 145 (93%) of these women glucose testing was performed. In total 77 (39%) women responded to the invitation to participate in this study and filled in the lifestyle questionnaire. About one third of the women met the recommendations for sufficient physical activity. A majority of them did not fulfil the Dutch guidelines on healthy diet - fruit intake 35.1%, vegetables intake 7.8%. Of the 74 invited GP's, 61 responded (82%), only 12 (20%) reported

2016 Journal of diabetes and metabolic disorders

191. Development and Evaluation of a Smartphone Application for Managing Gestational Diabetes Mellitus Full Text available with Trip Pro

Development and Evaluation of a Smartphone Application for Managing Gestational Diabetes Mellitus The purpose of this study was to develop and evaluate an application (app) that provides tailored recommendations based on lifestyle and clinical data entered by the user.Knowledge and functions required for the gestational diabetes mellitus (GDM) management app were extracted from clinical practice guidelines and evaluated through an online survey. Common and tailored recommendations were (...) usefulness score was 5.0 out of 7, respectively.The GDM management knowledge and tailored recommendations obtained in this study could be of help in managing GDM.

2016 Healthcare informatics research

192. Could gestational diabetes mellitus be managed through dietary bioactive compounds? Current knowledge and future perspectives Full Text available with Trip Pro

Could gestational diabetes mellitus be managed through dietary bioactive compounds? Current knowledge and future perspectives Gestational diabetes mellitus (GDM) is a serious problem growing worldwide that needs to be addressed with urgency in consideration of the resulting severe complications for both mother and fetus. Growing evidence indicates that a healthy diet rich in fruit, vegetables, nuts, extra-virgin olive oil and fish has beneficial effects in both the prevention and management

2016 The British journal of nutrition

193. Diagnosis a posteriori? Assessing gestational diabetes screening and management in Morocco Full Text available with Trip Pro

Diagnosis a posteriori? Assessing gestational diabetes screening and management in Morocco In Morocco, gestational diabetes affects 1 in 10 pregnant women, but knowledge about screening and management practices outside university settings is limited.To provide a comprehensive picture about the current situation of screening and management of gestational diabetes at different levels of care and to highlight existing challenges.We conducted a descriptive mixed methods study in the districts of Al (...) for the management of non-pregnant diabetic patients.Decentralization of screening for gestational diabetes and initial management of uncomplicated cases at the primary level of care could ease access to care and reduce the number of mothers who are diagnosed after a complication occurred.

2016 Global health action

194. Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin? Full Text available with Trip Pro

Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin? Gestational diabetes mellitus (GDM) complicates a significant number of pregnancies. Blood glucose control improves perinatal outcomes. Medical nutrition therapy is the foundation in management. Aim of This Study. To evaluate efficacy of metformin in comparison to insulin for managing GDM. Methods. In prospective randomized comparative study, 150 antenatal women whose pregnancies had been complicated by GDM and did

2016 International journal of reproductive medicine Controlled trial quality: uncertain

195. Improve Detection and Management of Gestational Diabetes Through the Primary Health Care Level in Morocco

Improve Detection and Management of Gestational Diabetes Through the Primary Health Care Level in Morocco Improve Detection and Management of Gestational Diabetes Through the Primary Health Care Level in Morocco - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Improve Detection and Management of Gestational Diabetes Through the Primary Health Care Level in Morocco The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02979756 Recruitment Status : Completed First Posted : December 2, 2016 Last Update Posted

2016 Clinical Trials

196. Effectiveness of cognitive-behavioral stress management on psychological stress and glycemic control in gestational diabetes: a randomized controlled trial. (Abstract)

Effectiveness of cognitive-behavioral stress management on psychological stress and glycemic control in gestational diabetes: a randomized controlled trial. This study was conducted to determine the effect of cognitive-behavioral stress management (CBT) on reducing psychological stress in diabetic pregnant women.This randomized controlled trial applied through pretest and post-test with control group was conducted on 88 eligible women with gestational diabetes. Women who had a stress score more (...) , the stress scores were significantly different before and after the intervention and women had a significant increase in the stress scores (p = 0.028). There was a significant difference between two groups in stress scores, two weeks after intervention (p = 0.001).Cognitive-behavioral stress management reduces stress in women with gestational diabetes and reducing stress may also improve the pregnancy outcomes, especially whose glycemic along with stress is not adequately controlled by medication.

2016 The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians Controlled trial quality: uncertain

197. What is known about options and approaches to intrapartum management of women with gestational diabetes mellitus (GDM)?

of cesarean delivery, major perineal trauma, low 5-min APGAR score, and neonatal ICU admission) for four risk-defined groups (low-risk, advanced maternal age, hypertension, and any type of diabetes mellitus) found that for the DM group optimal time of delivery was 40 weeks 3 days to 41 weeks 1 day. 46 S A 1993 randomized trial found that in women with uncomplicated insulin-requiring gestational or class B pregestational diabetes, expectant management of pregnancy after 38 weeks' gestation did not reduce (...) What is known about options and approaches to intrapartum management of women with gestational diabetes mellitus (GDM)? KTA Evidence Summary: Intrapartum Management of Patients with Gestational Diabetes Mellitus (GDM) Page 1 of 19 May 2010 May 2010 – Knowledge to Action Evidence Summary What is known about options and approaches to fetal surveillance and intrapartum management of women with gestational diabetes mellitus (GDM)? This report aims to summarize the evidence around the intrapartum

2010 OHRI Knowledge to Action

198. Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min) Full Text available with Trip Pro

, the management of patients with diabetes and CKD stage 3b or higher (eGFR <45 mL/min) remains problematic. Many guidance-providing documents have been produced on the management of patients with diabetes to prevent or delay the progression to CKD, mostly defined as the presence of micro- and macro-albuminuria. However, none of these documents specifically deal with the management of patients with CKD stage 3b or higher (eGFR <45 mL/min). There is a paucity of well-designed, prospective studies (...) Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min) We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min) | Nephrology Dialysis Transplantation | Oxford

2015 European Renal Best Practice

199. The use of iron salts, elevated levels of hemoglobin and serum ferritin during gestation and the risk of developing gestational diabetes: a systematic review

The use of iron salts, elevated levels of hemoglobin and serum ferritin during gestation and the risk of developing gestational diabetes: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr (...) of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group

2018 PROSPERO

200. Gestational Trophoblastic Disease

, and the interval between the initial diagnosis of metastatic GTN and the subsequent diagnosis of brain metastases can be long [12]. The EOTTD expressed a strong preference for MRI over CT for neurologic staging in a study that assessed the level of agreement among an expert panel regarding the management of patients with GTD [6]. However, in the setting of urgent neurologic findings that are due to space-occupying or hemorrhagic metastases, the ACR ACR Appropriateness Criteria ® 10 Gestational Trophoblastic (...) to sustain an adequate response to chemotherapy. Given the small number of patients who develop quiescent GTD, treatment can be challenging and management remains anecdotal. This disorder usually follows a molar pregnancy but can follow any gestational event. Typically, laboratory evaluation shows very low but persistent levels of ß-hCG (for at least 3 months) despite chemotherapy and, occasionally, even surgery, with no imaging or clinical evidence of GTN [2,70]. Quiescent GTD is biochemically monitored

2019 American College of Radiology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>